Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia
Pedro Caldana Gordon,1,2 Josefa Cynara Xavier,2 Mario Rodrigues Louzã21Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, Brazil; 2Schizophrenia Research Program, Institute of Psychiatry, Hospital das Clínicas, Faculdade de Medici...
Guardado en:
Autores principales: | Gordon PC, Xavier JC, Louzã MR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6c4ed9cb3e4414dbbcc5c52d80fb2e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Mario Louzã, et al.
Publicado: (2010) -
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã M, et al.
Publicado: (2011) -
Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki K, et al.
Publicado: (2017) -
Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review
por: Miguel CS, et al.
Publicado: (2015) -
Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia
por: Kim JH, et al.
Publicado: (2015)